Oncogene DEK is highly expressed in lung cancerous tissues and positively regulates cell proliferation as well as invasion
DEK is a protein ubiquitously expressed in multicellular organisms as well as certain unicellular organisms. It is associated with the regulation of cell proliferation, differentiation, migration, apoptosis, senescence, self-renewal and DNA repairing. In tumor cells it is associated with the carcinogenesis process, however there have been few previous studies into the expression of DEK in lung cancer. In the present study the expression level of DEK mRNA and protein was detected in lung cancer tissues and non-cancerous counterparts by performing reverse transcription-quantitative polymerase chain reaction and immunohistochemical staining. It was revealed that the expression of DEK was increased in lung cancer tissues compared with normal tissue. Knock-down and over-expression of DEK in A549 cells were performed to determine the role of DEK in tumor formation. An MTT assay, colony formation assay and Matrigel invasion assay demonstrated that DEK positively regulated cell proliferation and invasion. These results suggest that DEK is highly expressed in lung cancer tissues and positively regulates cell proliferation and invasion.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Oncology letters - 15(2018), 6 vom: 29. Juni, Seite 8573-8581 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhou, Qian-Cheng [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 01.10.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3892/ol.2018.8436 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM284902063 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM284902063 | ||
| 003 | DE-627 | ||
| 005 | 20231225044206.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3892/ol.2018.8436 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0949.xml |
| 035 | |a (DE-627)NLM284902063 | ||
| 035 | |a (NLM)29844811 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhou, Qian-Cheng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Oncogene DEK is highly expressed in lung cancerous tissues and positively regulates cell proliferation as well as invasion |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.10.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a DEK is a protein ubiquitously expressed in multicellular organisms as well as certain unicellular organisms. It is associated with the regulation of cell proliferation, differentiation, migration, apoptosis, senescence, self-renewal and DNA repairing. In tumor cells it is associated with the carcinogenesis process, however there have been few previous studies into the expression of DEK in lung cancer. In the present study the expression level of DEK mRNA and protein was detected in lung cancer tissues and non-cancerous counterparts by performing reverse transcription-quantitative polymerase chain reaction and immunohistochemical staining. It was revealed that the expression of DEK was increased in lung cancer tissues compared with normal tissue. Knock-down and over-expression of DEK in A549 cells were performed to determine the role of DEK in tumor formation. An MTT assay, colony formation assay and Matrigel invasion assay demonstrated that DEK positively regulated cell proliferation and invasion. These results suggest that DEK is highly expressed in lung cancer tissues and positively regulates cell proliferation and invasion | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a DEK | |
| 650 | 4 | |a carcinogenesis | |
| 650 | 4 | |a lung cancer | |
| 700 | 1 | |a Deng, Xue-Feng |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Qiao, Ming-Xu |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Huan-Huan |e verfasserin |4 aut | |
| 700 | 1 | |a Qian, Zhen |e verfasserin |4 aut | |
| 700 | 1 | |a Hou, Ling-Ling |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Hong-Gang |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncology letters |d 2010 |g 15(2018), 6 vom: 29. Juni, Seite 8573-8581 |w (DE-627)NLM201171317 |x 1792-1082 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2018 |g number:6 |g day:29 |g month:06 |g pages:8573-8581 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3892/ol.2018.8436 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2018 |e 6 |b 29 |c 06 |h 8573-8581 | ||